Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy

Free Radical Biology and Medicine

Volumn 43, Issue 3, 2007, Pages 332-347

  Lambeth, J David ^a  

^a Department of Pathology and Laboratory Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THYROID HORMONE;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CHRONIC DISEASE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DNA DAMAGE; GENE MUTATION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INNATE IMMUNITY; LIPID DEGRADATION; LUNG FIBROSIS; MALIGNANT NEOPLASTIC DISEASE; NATURAL SELECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; THYROID HORMONE SYNTHESIS; TISSUE INJURY;

ALZHEIMER DISEASE; ANIMALS; BONE RESORPTION; BRAIN; CARDIOVASCULAR PHYSIOLOGY; CHRONIC DISEASE; DIABETIC ANGIOPATHIES; EAR, INNER; ENDOCRINE SYSTEM; HUMANS; HYPERTENSION; IMMUNITY, NATURAL; KIDNEY DISEASES; LUNG; NADPH OXIDASE; NEOPLASMS; NERVOUS SYSTEM; OSTEOARTHRITIS; REACTIVE OXYGEN SPECIES;

EID: 34347257042     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.03.027     Document Type: Review

References (203)

1. Babior B.M., Lambeth J.D., and Nauseef W. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397 (2002) 342-344
2. Vignais P.V. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell. Mol. Life Sci. 59 (2002) 1428-1459
3. Reeves E.P., Lu H., Jacobs H.L., Messina C.G., Bolsover S., Gabella G., Potma E.O., Warley A., Roes J., and Segal A.W. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416 (2002) 291-297
4. Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77 (2005) 598-625
5. Hampton M.B., Kettle A.J., and Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92 (1998) 3007-3017
6. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J. Mol. Med. 76 (1998) 676-681
7. Nathan C.F., and Hibbs Jr. J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3 (1991) 65-70
8. DeCoursey T.E. During the respiratory burst, do phagocytes need proton channels or potassium channels, or both?. Sci. STKE 2004 (2004) pe21
9. Murphy R., and DeCoursey T.E. Charge compensation during the phagocyte respiratory burst. Biochim. Biophys. Acta 1757 (2006) 996-1011
10. Sasaki M., Takagi M., and Okamura Y. A voltage sensor-domain protein is a voltage-gated proton channel[see comment]. Science 312 (2006) 589-592
11. Ramsey I.S., Moran M.M., Chong J.A., and Clapham D.E. A voltage-gated proton-selective channel lacking the pore domain. Nature 440 (2006) 1213-1216
12. Segal A.W. The NADPH oxidase and chronic granulomatous disease. Mol. Med. Today 2 (1996) 129-135
13. Malech J.L., and Gallin J.I. Immunology of neutrophils in human diseases. N. Engl. J. Med. 317 (1987) 687-694
14. Kuehl F.A., Humes J.L., Ham E.A., Egan R.W., and Dougherty H.W. Inflammation: the role of peroxidase-derived products. Adv. Prost.Thromb. Res. 6 (1980) 77-86
15. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 320 (1989) 365-376
16. Moraes T.J., Zurawska J.H., and Downey G.P. Neutrophil granule contents in the pathogenesis of lung injury. Curr. Opin. Hematol. 13 (2006) 21-27
17. Hyers T.M., and Fowler A.A. Adult respiratory distress syndrome: causes, morbidity, and mortality. Fed. Proc. 45 (1986) 25-29
18. Cochrane C.G., and Gimbrone M.A. Biological oxidants: generation and injurious consequences (1992), Academic Press, San Diego
19. Winyard P.G., Blake D.R., and Evans C.H. Free radicals and inflammation (2000), Birkhèauser Verlag, Basel
20. Conner G.E., Salathe M., and Forteza R. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am. J. Respir. Crit. Care Med. 166 (2002) S57-S61
21. Ratner A.J., and Prince A. Lactoperoxidase. New recognition of an "old" enzyme in airway defenses. Am. J. Respir. Cell Mol. Biol. 22 (2000) 642-644
22. Geiszt M., Witta J., Baffi J., Lekstrom K., and Leto T.L. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 17 (2003) 1502-1504
23. Leto T.L., and Geiszt M. Role of Nox family NADPH oxidases in host defense. Antioxid. Redox Signal. 8 (2006) 1549-1561
24. Kawahara T., Teshima S., Oka A., Sugiyama T., Kishi K., and Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69 (2001) 4382-4389
25. Lee P.L., West C., Crain K., and Wang L. Genetic polymorphisms and susceptibility to lung disease. J. Negat. Results Biomed. 5 (2006) 5
26. Ha E.M., Oh C.T., Bae Y.S., and Lee W.J. A direct role for dual oxidase in Drosophila gut immunity. Science 310 (2005) 847-850
27. Dhaunsi G.S., Paintlia M.K., Kaur J., and Turner R.B. NADPH oxidase in human lung fibroblasts. J. Biomed. Sci. 11 (2004) 617-622
28. Larios J.M., Budhiraja R., Fanburg B.L., and Thannickal V.J. Oxidative protein cross-linking reactions involving L-tyrosine in transforming growth factor-beta1-stimulated fibroblasts. J. Biol. Chem. 276 (2001) 17437-17441
29. Waghray M., Cui Z., Horowitz J.C., Subramanian I.M., Martinez F. J., Toews G.B., and Thannickal V.J. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J. 19 (2005) 854-856
30. Pantano C., Anathy V., Ranjan P., Heintz N.H., and Janssen-Heininger Y. M. Non-phagocytic oxidase 1 causes death in lung epithelial cells via a TNF-R1-JNK signaling axis. Am. J. Respir. Cell Mol. Biol. 36 (2007) 473-479
31. Meng Q.R., Gideon K.M., Harbo S.J., Renne R.A., Lee M.K., Brys A.M., and Jones R. Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal. Toxicol. 18 (2006) 555-568
32. Zhang X., Shan P., Jiang G., Cohn L., and Lee P.J. Toll-like receptor 4 deficiency causes pulmonary emphysema. J. Clin. Invest. 116 (2006) 3050-3059
33. Vural H., Aksoy N., Ceylan E., Gencer M., and Ozguner F. Leukocyte oxidant and antioxidant status in asthmatic patients. Arch. Med. Res. 36 (2005) 502-506
34. Bowler R.P., and Crapo J.D. Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol. 110 (2002) 349-356
35. Hoidal J.R., Brar S.S., Sturrock A.B., Sanders K.A., Dinger B., Fidone S., and Kennedy T.P. The role of endogenous NADPH oxidases in airway and pulmonary vascular smooth muscle function. Antioxid. Redox Signal. 5 (2003) 751-758
36. Ritsick D.R., and Lambeth J.D. Spring brings breezes, wheezes, and pollen oxidases. J. Clin. Invest. 115 (2005) 2067-2069
37. Boldogh I., Bacsi A., Choudhury B.K., Dharajiya N., Alam R., Hazra T.K., Mitra S., Goldblum R.M., and Sur S. ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J. Clin. Invest. 115 (2005) 2169-2179
38. Bacsi A., Dharajiya N., Choudhury B.K., Sur S., and Boldogh I. Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J. Allergy Clin. Immunol. 116 (2005) 836-843
39. Djordjevic T., BelAiba R.S., Bonello S., Pfeilschifter J., Hess J., and Gorlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 519-525
40. Goyal P., Weissmann N., Grimminger F., Hegel C., Bader L., Rose F., Fink L., Ghofrani H.A., Schermuly R.T., Schmidt H.H., Seeger W., and Hanze J. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic. Biol. Med. 36 (2004) 1279-1288
41. Lassegue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R277-R297
42. Brandes R.P. Role of NADPH oxidases in the control of vascular gene expression. Antioxid. Redox Signal. 5 (2003) 803-811
43. Petry A., Djordjevic T., Weitnauer M., Kietzmann T., Hess J., and Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid. Redox Signal. 8 (2006) 1473-1484
44. Lassegue B., Sorescu D., Szocs K., Yin Q., Akers M., Zhang Y., Grant S.L., Lambeth J.D., and Griendling K.K. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88 (2001) 888-894
45. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., Pagano P.J., and Schiffrin E.L. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90 (2002) 1205-1213
46. Suh Y.-A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., and Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
47. Clempus R.E., Sorescu D., Dikalova A.E., Pounkova L., Jo P., Sorescu G.P., Schmidt H.H., Lassegue B., and Griendling K.K. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 42-48
48. Deliri H., and McNamara C.A. Nox 4 regulation of vascular smooth muscle cell differentiation marker gene expression. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 12-14
49. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., and Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14483-14488
50. Di Wang H., Hope S., Du Y., Quinn M.T., Cayatte A., Pagano P.J., and Cohen R.A. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension 33 (1999) 1225-1232
51. Banfi B., Molinar G., Maturana A., Steger K., Hegedus B., Demaurex N., and Krause K.-H. A Ca2+-activated NADPH oxidase in testis, spleen and lymph nodes. J. Biol. Chem. 276 (2001) 37594-37601
52. Cave A.C., Brewer A.C., Narayanapanicker A., Ray R., Grieve D.J., Walker S., and Shah A.M. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 8 (2006) 691-728
53. Li J., Stouffs M., Serrander L., Banfi B., Bettiol E., Charnay Y., Steger K., Krause K.H., and Jaconi M.E. The NADPH oxidase NOX4 drives cardiac differentiation: role in regulating cardiac transcription factors and MAP kinase activation. Mol. Biol. Cell 17 (2006) 3978-3988
54. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., Dikalov S., and Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97 (2005) 900-907
55. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., Cave A.C., and Shah A.M. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93 (2003) 802-805
56. Grieve D.J., Byrne J.A., Siva A., Layland J., Johar S., Cave A.C., and Shah A.M. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J. Am. Coll. Cardiol. 47 (2006) 817-826
57. Johar S., Cave A.C., Narayanapanicker A., Grieve D.J., and Shah A.M. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J. 20 (2006) 1546-1548
58. Krijnen P.A., Meischl C., Hack C.E., Meijer C.J., Visser C.A., Roos D., and Niessen H.W. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J. Clin. Pathol. 56 (2003) 194-199
59. Guggilam A., Haque M., Lucchesi P.A., and Francis J. Cytokines modulate oxidative stress in ischemia reperfusion-induced heart injury in rats: role of gp91phox and its homologs, Nox1 and Nox4. FASEB J. 20 (2006) A1155
60. Kim Y.M., Guzik T.J., Zhang Y.H., Zhang M.H., Kattach H., Ratnatunga C., Pillai R., Channon K.M., and Casadei B. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ. Res. 97 (2005) 629-636
61. Jung O., Schreiber J.G., Geiger H., Pedrazzini T., Busse R., and Brandes R.P. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109 (2004) 1795-1801
62. Griendling K.K., and Alexander R.W. Oxidative stress and cardiovascular disease. Circulation 96 (1997) 3264-3265
63. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., Valppu L., Quinn M.T., Lambeth J.D., Vega J.D., Taylor W.R., and Griendling K.K. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105 (2002) 1429-1435
64. Wingler K., Wunsch S., Kreutz R., Rothermund L., Paul M., and Schmidt H.H. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic. Biol. Med. 31 (2001) 1456-1464
65. Menshikov M., Plekhanova O., Cai H., Chalupsky K., Parfyonova Y., Bashtrikov P., Tkachuk V., and Berk B.C. Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 801-807
66. Katsuyama M., Fan C., Arakawa N., Nishinaka T., Miyagishi M., Taira K., and Yabe-Nishimura C. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem. J. 386 (2005) 255-261
67. Moe K.T., Aulia S., Jiang F., Chua Y.L., Koh T.H., Wong M.C., and Dusting G.J. Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J. Cell. Mol. Med. 10 (2006) 231-239
68. Akasaki T., Ohya Y., Kuroda J., Eto K., Abe I., Sumimoto H., and Iida M. Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system. Hypertens. Res. 29 (2006) 813-820
69. Katsuyama M., Fan C., and Yabe-Nishimura C. NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha. J. Biol. Chem. 277 (2002) 13438-13442
70. Dikalova A., Clempus R., Lassegue B., Cheng G., McCoy J., Dikalov S., San Martin A., Lyle A., Weber D.S., Weiss D., Taylor W.R., Schmidt H.H., Owens G.K., Lambeth J.D., and Griendling K.K. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112 (2005) 2668-2676
71. Laude K., Cai H., Fink B., Hoch N., Weber D.S., McCann L., Kojda G., Fukai T., Schmidt H.H., Dikalov S., Ramasamy S., Gamez G., Griendling K.K., and Harrison D.G. Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am. J. Physiol. 288 (2005) H7-H12
72. Weber D.S., Rocic P., Mellis A.M., Laude K., Lyle A.N., Harrison D.G., and Griendling K.K. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am. J. Physiol. 288 (2005) H37-H42
73. Gavazzi G., Banfi B., Deffert C., Fiette L., Schappi M., Herrmann F., and Krause K.H. Decreased blood pressure in NOX1-deficient mice. FEBS Lett. 580 (2006) 497-504
74. Matsuno K., Yamada H., Iwata K., Jin D., Katsuyama M., Matsuki M., Takai S., Yamanishi K., Miyazaki M., Matsubara H., and Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
75. Just A., Olson A.J., Whitten C.L., and Arendshorst W.J. Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am. J. Physiol. 292 (2007) H83-H92
76. VanBuul J.D., Fernandez-Borja M., Anthony E.C., and Hordijk P.L. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid. Redox Signal. 7 (2005) 308-317
77. Zhou M.S., Hernandez Schulman I., Pagano P.J., Jaimes E.A., and Raij L. Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 47 (2006) 81-86
78. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24 (2003) 471-478
79. Guzik T.J., Sadowski J., Guzik B., Jopek A., Kapelak B., Przybylowski P., Wierzbicki K., Korbut R., Harrison D.G., and Channon K.M. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 333-339
80. Hwang J., Ing M.H., Salazar A., Lassegue B., Griendling K., Navab M., Sevanian A., and Hsiai T.K. Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression. Implication for native LDL oxidation. Circ. Res. 278 (2003) 19634-19641
81. Sorescu G.P., Song H., Tressel S.L., Hwang J., Dikalov S., Smith D.A., Boyd N.L., Platt M.O., Lassegue B., Griendling K.K., and Jo H. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ. Res. 95 (2004) 773-779
82. Jo H., Song H., and Mowbray A. Role of NADPH oxidases in disturbed flow- and BMP4- induced inflammation and atherosclerosis. Antioxid. Redox Signal. 8 (2006) 1609-1619
83. Szocs K., Lassegue B., Sorescu D., Hilenski L.L., Valppu L., Couse T.L., Wilcox J.N., Quinn M.T., Lambeth J.D., and Griendling K.K. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 21-27
84. Loffredo L., Marcoccia A., Pignatelli P., Andreozzi P., Borgia M.C., Cangemi R., Chiarotti F., and Violi F. Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur. J. Heart 28 (2007) 608-612
85. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., Li H., Bodenschatz M., August M., Kleschyov A.L., Tsilimingas N., Walter U., Forstermann U., Meinertz T., Griendling K., and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90 (2002) E58-E65
86. Shen W.L., Gao P.J., Che Z.Q., Ji K.D., Yin M., Yan C., Berk B.C., and Zhu D.L. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem. Biophys. Res. Commun. 339 (2006) 337-343
87. Dusting G.J., Selemidis S., and Jiang F. Mechanisms for suppressing NADPH oxidase in the vascular wall. Mem. Inst. Oswaldo Cruz 100 Suppl. 1 (2005) 97-103
88. Ushio-Fukai M., and Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell. Biochem. 264 (2004) 85-97
89. Arbiser J.L., Petros J.A., Klafter R., Govindajaran B., McLaughlin E.R., Brown L.F., Cohen C., Moses M., Kilroy S., Arnold R.S., and Lambeth J.D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 715-720
90. Imanishi T., Hano T., and Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J. Hypertens. 23 (2005) 97-104
91. Hammes H.P. Pathophysiological mechanisms of diabetic angiopathy. J. Diabetes Complications 17 (2003) 16-19
92. Callaghan M.J., Ceradini D.J., and Gurtner G.C. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid. Redox Signal. 7 (2005) 1476-1482
93. Weidig P., McMaster D., and Bayraktutan U. High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells. Diabetes Obes. Metab. 6 (2004) 432-441
94. Ulker S., McMaster D., McKeown P.P., and Bayraktutan U. Antioxidant vitamins C and E ameliorate hyperglycaemia-induced oxidative stress in coronary endothelial cells. Diabetes Obes. Metab. 6 (2004) 442-451
95. Wendt M.C., Daiber A., Kleschyov A.L., Mulsch A., Sydow K., Schulz E., Chen K., Keaney Jr. J.F., Lassegue B., Walter U., Griendling K.K., and Munzel T. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic. Biol. Med. 39 (2005) 381-391
96. Vecchione C., Aretini A., Marino G., Bettarini U., Poulet R., Maffei A., Sbroggio M., Pastore L., Gentile M.T., Notte A., Iorio L., Hirsch E., Tarone G., and Lembo G. Selective Rac-1 inhibition protects from diabetes-induced vascular injury. Circ. Res. 98 (2006) 218-225
97. Vecchione C., Gentile M.T., Aretini A., Marino G., Poulet R., Maffei A., Passarelli F., Landolfi A., Vasta A., and Lembo G. A novel mechanism of action for statins against diabetes-induced oxidative stress. Diabetologia 50 (2007) 874-880
98. Zhang M., Kho A.L., Anilkumar N., Chibber R., Pagano P.J., Shah A.M., and Cave A.C. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113 (2006) 1235-1243
99. Geiszt M., Kopp J.B., Varnai P., and Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA 97 (2000) 8010-8014
100. Shiose A., Kuroda J., Tsuruya K., Hirai M., Hirakata H., Naito S., Hattori M., Sakaki Y., and Sumimoto H. A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276 (2001) 1417-1423
101. Asaba K., Tojo A., Onozato M.L., Goto A., Quinn M.T., Fujita T., and Wilcox C.S. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 67 (2005) 1890-1898
102. Miyata K., Rahman M., Shokoji T., Nagai Y., Zhang G.X., Sun G.P., Kimura S., Yukimura T., Kiyomoto H., Kohno M., Abe Y., and Nishiyama A. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J. Am. Soc. Nephrol. 16 (2005) 2906-2912
103. Yang Z., Asico L.D., Yu P., Wang Z., Jones J.E., Escano C.S., Wang X., Quinn M.T., Sibley D.R., Romero G.G., Felder R.A., and Jose P.A. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 (2006) R96-R104
104. Zhang Z., Rhinehart K., Kwon W., Weinman E., and Pallone T.L. ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species. Am. J. Physiol. 287 (2004) H773-H781
105. Chabrashvili T., Kitiyakara C., Blau J., Karber A., Aslam S., Welch W.J., and Wilcox C.S. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R117-R124
106. Li N., Zhang G., Yi F.X., Zou A.P., and Li P.L. Activation of NAD(P)H oxidase by outward movements of H+ ions in renal medullary thick ascending limb of Henle. Am. J. Physiol. Renal Physiol. 289 (2005) F1048-F1056
107. Gorin Y., Ricono J.M., Kim N.H., Bhandari B., Choudhury G.G., and Abboud H.E. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. Renal Physiol. 285 (2003) F219-F229
108. Hsieh T.J., Zhang S.L., Filep J.G., Tang S.S., Ingelfinger J.R., and Chan J.S. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143 (2002) 2975-2985
109. Ohshiro Y., Ma R.C., Yasuda Y., Hiraoka-Yamamoto J., Clermont A.C., Isshiki K., Yagi K., Arikawa E., Kern T.S., and King G.L. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase c{beta}-null mice. Diabetes 55 (2006) 3112-3120
110. Han H.J., Lee Y.J., Park S.H., Lee J.H., and Taub M. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 288 (2005) F988-F996
111. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., and Abboud H.E. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280 (2005) 39616-39626
112. Vaziri N.D., Dicus M., Ho N.D., Boroujerdi-Rad L., and Sindhu R.K. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int. 63 (2003) 179-185
113. Koroliczuk A., Chibowski D., Beltowski J., and Wojcicka G. Selected markers of oxidative stress in rats with active Heymann nephritis. Med. Sci. Monit. 7 (2001) 369-376
114. Nishiyama A., Yao L., Nagai Y., Miyata K., Yoshizumi M., Kagami S., Kondo S., Kiyomoto H., Shokoji T., Kimura S., Kohno M., and Abe Y. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43 (2004) 841-848
115. Kondo S., Shimizu M., Urushihara M., Tsuchiya K., Yoshizumi M., Tamaki T., Nishiyama A., Kawachi H., Shimizu F., Quinn M.T., Lambeth D.J., and Kagami S. Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat. J. Am. Soc. Nephrol. 17 (2006) 783-794
116. Devarajan P. Cellular and molecular derangements in acute tubular necrosis. Curr. Opin. Pediatr. 17 (2005) 193-199
117. Wilcox C.S. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R913-R935
118. Nishiyama A., Yoshizumi M., Hitomi H., Kagami S., Kondo S., Miyatake A., Fukunaga M., Tamaki T., Kiyomoto H., Kohno M., Shokoji T., Kimura S., and Abe Y. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J. Am. Soc. Nephrol. 15 (2004) 306-315
119. Garvin J.L., and Ortiz P.A. The role of reactive oxygen species in the regulation of tubular function. Acta Physiol. Scand. 179 (2003) 225-232
120. Beltowski J., Wojcicka G., Marciniak A., and Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci. 74 (2004) 2987-3000
121. Morena M., Delbosc S., Dupuy A.M., Canaud B., and Cristol J.P. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial. Int. 9 (2005) 37-46
122. Szatrowski T., and Nathan C. Production of large amounts of hydrogen peroxide by humor tumor cells. Cancer Res. 51 (1991) 794-798
123. Chamulitrat W., Schmidt R., Tomakidi P., Stremmel W., Chunglok W., Kawahara T., and Rokutan K. Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene 22 (2003) 6045-6053
124. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
125. Burdon R. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18 (1995) 775-794
126. Burdon R.H. Control of cell proliferation by reactive oxygen species. Biochem. Soc.Trans. 24 (1996) 1028-1032
127. Brar S.S., Kennedy T.P., Sturrock A.B., Huecksteadt T.P., Quinn M.T., Whorton A.R., and Hoidal J.R. An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am. J. Physiol. Cell Physiol. 282 (2002) C1212-C1224
128. Brar S.S., Corbin Z., Kennedy T.P., Hemendinger R., Thornton L., Bommarius B., Arnold R.S., Whorton A.R., Sturrock A.B., Huecksteadt T.P., Quinn M.T., Krenitsky K., Ardie K.G., Lambeth J.D., and Hoidal J.R. NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am. J. Physiol. Cell Physiol. 285 (2003) C353-C369
129. Lim S.D., Sun C., Lambeth J.D., Marshall F., Amin M., Chung L., Petros J.A., and Arnold R.S. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62 (2005) 200-207
130. Cheng G., Cao Z., Xu X., van Meir E.G., and Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269 (2001) 131-140
131. Kawahara T., Kohjima M., Kuwano Y., Mino H., Teshima-Kondo S., Takeya R., Tsunawaki S., Wada A., Sumimoto H., and Rokutan K. Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am. J. Physiol. Cell Physiol. 288 (2005) C450-C457
132. Fu X., Beer D.G., Behar J., Wands J., Lambeth D., and Cao W. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J. Biol. Chem. 281 (2006) 20368-20382
133. Lambeth J.D. From SOD to Phox to Nox: a personal account of the evolving views of reactive oxygen species. Recent Adv. Res. Updates 4 (2003) 31-40
134. Geiszt M., Lekstrom K., Brenner S., Hewitt S.M., Dana R., Malech H.L., and Leto T.L. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91(phox) in the regulated production of superoxide by phagocytes. J. Immunol. 171 (2003) 299-306
135. Szanto I., Rubbia-Brandt L., Kiss P., Steger K., Banfi B., Kovari E., Herrmann F., Hadengue A., and Krause K.H. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J. Pathol. 207 (2005) 164-176
136. Fukuyama M., Rokutan K., Sano T., Miyake H., Shimada M., and Tashiro S. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett. 221 (2005) 97-104
137. Mitsushita J., Lambeth J.D., and Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res. 64 (2004) 3580-3585
138. Ranjan P., Anathy V., Burch P.M., Weirather K., Lambeth J.D., and Heintz N.H. Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells. Antioxid. Redox Signal. 8 (2006) 1447-1459
139. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
140. Arnold R.S., Shi J., Murad E., Whalen A.M., Sun C.Q., Polavarapu R., Parthasarathy S., Petros J.A., and Lambeth J.D. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5550-5555
141. Vaquero E.C., Edderkaoui M., Pandol S.J., Gukovsky I., and Gukovskaya A.S. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J. Biol. Chem. 279 (2004) 34643-34654
142. Mochizuki T., Furuta S., Mitsushita J., Shang W.H., Ito M., Yokoo Y., Yamaura M., Ishizone S., Nakayama J., Konagai A., Hirose K., Kiyosawa K., and Kamata T. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene (2006)
143. Rintoul R.C., and Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin. Sci. (Lond.) 102 (2002) 417-424
144. Lochter A., and Bissell M.J. Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol. 6 (1995) 165-173
145. Honore S., Kovacic H., Pichard V., Briand C., and Rognoni J.B. Alpha2beta1-integrin signaling by itself controls G1/S transition in a human adenocarcinoma cell line (Caco-2): implication of NADPH oxidase-dependent production of ROS. Exp. Cell Res. 285 (2003) 59-71
146. Morazzani M., de Carvalho D.D., Kovacic H., Smida-Rezgui S., Briand C., and Penel C. Monolayer versus aggregate balance in survival process for EGF-induced apoptosis in A431 carcinoma cells: implication of ROS-P38 MAPK-integrin alpha2beta1 pathway. Int. J. Cancer 110 (2004) 788-799
147. Edderkaoui M., Hong P., Vaquero E.C., Lee J.K., Fischer L., Friess H., Buchler M.W., Lerch M.M., Pandol S.J., and Gukovskaya A.S. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G1137-G1147
148. Suzukawa K., Miura K., Mitsushita J., Resau J., Hirose K., Crystal R., and Kamata T. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species. J. Biol. Chem. 275 (2000) 13175-13178
149. Pannaccione A., Secondo A., Scorziello A., Cali G., Taglialatela M., and Annunziato L. Nuclear factor-kappaB activation by reactive oxygen species mediates voltage-gated K+ current enhancement by neurotoxic beta-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones. J. Neurochem. 94 (2005) 572-586
150. Colton C., Yao J., Grossman Y., and Gilbert D. The effect of xanthine/xanthine oxidase generated reactive oxygen species on synaptic transmission. Free Radic. Res. Commun. 14 (1991) 385-393
151. Pellmar T.C., Gilman S.C., Keyser D.O., Lee K.H., Lepinski D.L., Livengood D., and Myers Jr. L.S. Reactive oxygen species on neural transmission. Ann. N.Y. Acad. Sci. 738 (1994) 121-129
152. Avshalumov M.V., Chen B.T., and Rice M.E. Mechanisms underlying H(2)O(2)-mediated inhibition of synaptic transmission in rat hippocampal slices. Brain Res. 882 (2000) 86-94
153. Giniatullin A.R., and Giniatullin R.A. Dual action of hydrogen peroxide on synaptic transmission at the frog neuromuscular junction. J. Physiol. 552 (2003) 283-293
154. Chen B.T., Avshalumov M.V., and Rice M.E. H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release. J. Neurophysiol. 85 (2001) 2468-2476
155. Giniatullin A.R., Darios F., Shakirzyanova A., Davletov B., and Giniatullin R. SNAP25 is a pre-synaptic target for the depressant action of reactive oxygen species on transmitter release. J. Neurochem. 98 (2006) 1789-1797
156. Sankarapandi S., Zweier J.L., Mukherjee G., Quinn M.T., and Huso D.L. Measurement and characterization of superoxide generation in microglial cells: evidence for an NADPH oxidase-dependent pathway. Arch. Biochem. Biophys. 353 (1998) 312-321
157. Green S.P., Cairns B., Rae J., Errett-Baroncini C., Hongo J.A., Erickson R.W., and Curnutte J.T. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J. Cereb. Blood Flow Metab. 21 (2001) 374-384
158. Vallet P., Charnay Y., Steger K., Ogier-Denis E., Kovari E., Herrmann F., Michel J.P., and Szanto I. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132 (2005) 233-238
159. Ibi M., Katsuyama M., Fan C., Iwata K., Nishinaka T., Yokoyama T., and Yabe-Nishimura C. NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. Free Radic. Biol. Med. 40 (2006) 1785-1795
160. Wilkinson B.L., and Landreth G.E. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J. Neuroinflammation 3 (2006) 30
161. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
162. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease-A double-edged sword. Neuron 35 (2002) 419-432
163. Mattson M.P. NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 30 (2005) 883-893
164. de la Monte S.M., and Wands J.R. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J. Alzheimers Dis. 9 (2006) 167-181
165. Aslan M., and Ozben T. Reactive oxygen and nitrogen species in Alzheimer's disease. Curr. Alzheimer Res. 1 (2004) 111-119
166. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23 (1997) 134-147
167. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., and Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21 (2001) 4183-4187
168. Bianca V.D., Dusi S., Bianchini E., Dal Pra I., and Rossi F. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J. Biol. Chem. 274 (1999) 15493-15499
169. Abramov A.Y., and Duchen M.R. The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 360 (2005) 2309-2314
170. Zekry D., Epperson T.K., and Krause K.H. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia?. IUBMB Life 55 (2003) 307-313
171. Tieu K., Ischiropoulos H., and Przedborski S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 55 (2003) 329-335
172. Przedborski S., and Ischiropoulos H. Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease. Antioxid. Redox Signal. 7 (2005) 685-693
173. Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., Parks J.P., Parker Jr. W.D., and Bennett Jr. J.P. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362 (1997) 77-86
174. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
175. Iravani M.M., Leung C.C., Sadeghian M., Haddon C.O., Rose S., and Jenner P. The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur. J. Neurosci. 22 (2005) 317-330
176. Qin L., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., Liu B., and Hong J.S. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279 (2004) 1415-1421
177. Block M.L., Li G., Qin L., Wu X., Pei Z., Wang T., Wilson B., Yang J., and Hong J.S. Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J. 20 (2006) 251-258
178. Niebroj-Dobosz I., Dziewulska D., and Kwiecinski H. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS). Fol. Neuropathol. 42 (2004) 151-156
179. Carri M.T., Ceroni M., Ferri A., Gabbianelli R., Casciati A., and Costa A. Neurochemistry of SOD1 and familial amyotrophic lateral sclerosis. Funct. Neurol. 16 (2001) 73-82
180. Ferri A., Nencini M., Casciati A., Cozzolino M., Angelini D.F., Longone P., Spalloni A., Rotilio G., and Carri M.T. Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J. 18 (2004) 1261-1263
181. Wu D.C., Re D.B., Nagai M., Ischiropoulos H., and Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 12132-12137
182. Banfi B., Malgrange B., Knisz J., Steger K., Dubois-Dauphin M., and Krause K.H. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 279 (2004) 46065-46072
183. Paffenholz R., Bergstrom R.A., Pasutto F., Wabnitz P., Munroe R.J., Jagla W., Heinzmann U., Marquardt A., Bareiss A., Laufs J., Russ A., Stumm G., Schimenti J.C., and Bergstrom D.E. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev. 18 (2004) 486-491
184. Kiss P.J., Knisz J., Zhang Y., Baltrusaitis J., Sigmund C.D., Thalmann R., Smith R.J., Verpy E., and Banfi B. Inactivation of NADPH oxidase organizer 1 results in severe imbalance. Curr. Biol. 16 (2006) 208-213
185. Riva C., Donadieu E., Magnan J., and Lavieille J.P. Age-related hearing loss in CD/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea. Exp. Gerontol. 42 (2007) 327-366
186. Mukherjea D., Whitworth C.A., Nandish S., Dunaway G.A., Rybak L.P., and Ramkumar V. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin. Neuroscience 139 (2006) 733-740
187. Dupuy C., Ohayon R., Valent A., Noe-Hudson M., Dee D., and Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. J. Biol. Chem. 274 (1999) 37265-37269
188. De Deken X., Wang D., Many M.C., Costagliola S., Libert F., Vassart G., Dumont J.E., and Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275 (2000) 23227-23233
189. Lambeth J.D., Cheng G., Arnold R.S., and Edens W.E. Novel homologs of gp91phox. Trends Biochem. Sci. 25 (2000) 459-461
190. Edens W.A., Sharling L., Cheng G., Shapira R., Kinkade J.M., Edens H.A., Tang X., Flaherty D.B., Benian G., and Lambeth J.D. Tyrosine cross-linking of extracellullar matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J. Cell Biol. 154 (2001) 879-891
191. De Deken X., Wang D., Dumont J.E., and Miot F. Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. Exp. Cell Res. 273 (2002) 187-196
192. Vigone M.C., Fugazzola L., Zamproni I., Passoni A., Di Candia S., Chiumello G., Persani L., and Weber G. Persistent mild hypothyroidism associated with novel sequence variants of the DUOX2 gene in two siblings. Hum. Mutat. 26 (2005) 395
193. Moreno J.C., Bikker H., Kempers M.J., van Trotsenburg A.S., Baas F., de Vijlder J.J., Vulsma T., and Ris-Stalpers C. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N. Engl. J. Med. 347 (2002) 95-102
194. Uchizono Y., Takeya R., Iwase M., Sasaki N., Oku M., Imoto H., Iida M., and Sumimoto H. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci. 80 (2006) 133-139
195. Hoeldtke R.D., Bryner K.D., McNeill D.R., Warehime S.S., Van Dyke K., and Hobbs G. Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J. Clin. Endocrinol. Metab. 88 (2003) 1624-1628
196. Nakayama M., Inoguchi T., Sonta T., Maeda Y., Sasaki S., Sawada F., Tsubouchi H., Sonoda N., Kobayashi K., Sumimoto H., and Nawata H. Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem. Biophys. Res. Commun. 332 (2005) 927-933
197. Yu J.H., Lim J.W., Kim H., and Kim K.H. NADPH oxidase mediates interleukin-6 expression in cerulein-stimulated pancreatic acinar cells. Int. J. Biochem. Cell Biol. 37 (2005) 1458-1469
198. Mahadev K., Motoshima H., Wu X., Ruddy J.M., Arnold R.S., Cheng G., Lambeth J.D., and Goldstein B.J. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell. Biol. 24 (2004) 1844-1854
199. Goldstein B.J., Mahadev K., and Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54 (2005) 311-321
200. Key L.L., Wolf W.C., Gundberg C.M., and Ries W.L. Superoxide and bone resorption. Bone 15 (1994) 431-436
201. Yang S., Madyashtha P., Bingel S., Ries W., and Key L. A new superoxide-generating oxidase in murine osteoclasts. J. Biol. Chem. 276 (2001) 5452-5458
202. Grange L., Nguyen M.V., Lardy B., Derouazi M., Campion Y., Trocme C., Paclet M.H., Gaudin P., and Morel F. NAD(P)H oxidase activity of Nox4 in chondrocytes is both inducible and involved in collagenase expression. Antioxid. Redox Signal. 8 (2006) 1485-1496
203. Lambeth J.D., Kawahara T., and Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 43 (2007) 319-331